Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH CIPLA PROCTER & GAMBLE HEALTH/
CIPLA
 
P/E (TTM) x 34.5 32.2 106.9% View Chart
P/BV x 10.5 5.2 203.4% View Chart
Dividend Yield % 2.0 0.6 354.9%  

Financials

 PROCTER & GAMBLE HEALTH   CIPLA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
CIPLA
Mar-23
PROCTER & GAMBLE HEALTH/
CIPLA
5-Yr Chart
Click to enlarge
High Rs5,3661,185 452.7%   
Low Rs3,883852 455.8%   
Sales per share (Unadj.) Rs740.7281.9 262.8%  
Earnings per share (Unadj.) Rs138.235.1 393.5%  
Cash flow per share (Unadj.) Rs155.249.7 312.5%  
Dividends per share (Unadj.) Rs95.008.50 1,117.6%  
Avg Dividend yield %2.10.8 246.2%  
Book value per share (Unadj.) Rs447.6289.2 154.8%  
Shares outstanding (eoy) m16.60807.15 2.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.23.6 172.8%   
Avg P/E ratio x33.529.0 115.4%  
P/CF ratio (eoy) x29.820.5 145.3%  
Price / Book Value ratio x10.33.5 293.3%  
Dividend payout %68.724.2 284.0%   
Avg Mkt Cap Rs m76,761822,164 9.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2,06238,301 5.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,296227,531 5.4%  
Other income Rs m1845,121 3.6%   
Total revenues Rs m12,480232,653 5.4%   
Gross profit Rs m3,24748,079 6.8%  
Depreciation Rs m28111,721 2.4%   
Interest Rs m81,095 0.7%   
Profit before tax Rs m3,14240,384 7.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m84712,029 7.0%   
Profit after tax Rs m2,29528,355 8.1%  
Gross profit margin %26.421.1 125.0%  
Effective tax rate %27.029.8 90.5%   
Net profit margin %18.712.5 149.8%  
BALANCE SHEET DATA
Current assets Rs m11,713168,051 7.0%   
Current liabilities Rs m6,79150,333 13.5%   
Net working cap to sales %40.051.7 77.4%  
Current ratio x1.73.3 51.7%  
Inventory Days Days26373 358.6%  
Debtors Days Days3437 5,277.6%  
Net fixed assets Rs m10,617117,318 9.0%   
Share capital Rs m1661,614 10.3%   
"Free" reserves Rs m7,265231,845 3.1%   
Net worth Rs m7,431233,460 3.2%   
Long term debt Rs m00-   
Total assets Rs m22,330290,067 7.7%  
Interest coverage x409.137.9 1,080.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.8 70.2%   
Return on assets %10.310.2 101.6%  
Return on equity %30.912.1 254.3%  
Return on capital %42.417.8 238.6%  
Exports to sales %022.6 0.0%   
Imports to sales %13.18.9 147.0%   
Exports (fob) Rs mNA51,516 0.0%   
Imports (cif) Rs m1,60520,202 7.9%   
Fx inflow Rs m1,46564,282 2.3%   
Fx outflow Rs m1,60520,202 7.9%   
Net fx Rs m-14044,080 -0.3%   
CASH FLOW
From Operations Rs m2,36032,377 7.3%  
From Investments Rs m-215-23,885 0.9%  
From Financial Activity Rs m-985-9,583 10.3%  
Net Cashflow Rs m1,160-968 -119.9%  

Share Holding

Indian Promoters % 0.0 13.4 -  
Foreign collaborators % 51.8 20.0 258.6%  
Indian inst/Mut Fund % 20.3 50.0 40.5%  
FIIs % 7.6 25.7 29.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 66.5 72.4%  
Shareholders   56,730 425,731 13.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Procter & Gamble Health vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs Cipla Share Price Performance

Period Procter & Gamble Health Cipla S&P BSE HEALTHCARE
1-Day -0.55% 1.94% 1.18%
1-Month -7.47% 1.25% -0.75%
1-Year -3.02% 68.02% 61.82%
3-Year CAGR -9.12% 22.53% 18.16%
5-Year CAGR 5.75% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.